0 items USD 0.00Search
Your search for "Drug Discovery" gave back 29 results.
RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation,...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
La Merie Publishing
November 2022
Price: USD 2,500.00
Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: a landscape analysis of companies, technologies, targets, investors and...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
La Merie Publishing
May 2020
Price: USD 2,350.00
This report bundle includes four reports about novel cancer targets which have in common a compelling target expression profile with a low risk of on...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
La Merie Publishing
July 2022
Price: USD 2,000.00
RNA-Targeted Small Molecules 2019: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective This...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
La Merie Publishing
September 2019
Price: USD 2,350.00
Claudin 6 (CLDN6) is a compelling tumor antigen. The tetraspan membrane protein is a member of the claudin family of tight junction proteins. CLDN6...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
La Merie Publishing
May 2022
Price: USD 560.00
This report provides a landscape description and analysis of chimeric antigen receptor-macrophage (CAR-M) platform technologies and stakeholders from...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
La Merie Publishing
February 2023
Price: USD 2,000.00
Cadherins are a family of glycoproteins responsible for calcium ion–dependent cell adhesion. There are more than 100 types of cadherins in humans,...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
La Merie Publishing
May 2022
Price: USD 450.00
This report evaluates G-protein–coupled receptor family C group 5 member D (GPRC5D) from an industry perspective for its suitability as a tumor-...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
La Merie Publishing
July 2022
Price: USD 670.00
This report evaluates Receptor tyrosine kinase-like Orphan Receptor 1 (ROR1) from an industry perspective for its suitability as a tumor-specific...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
La Merie Publishing
June 2022
Price: USD 1,170.00
Alzheimer’s disease is the most common cause of dementia among older people. It is a devastating condition for those afflicted as well as their...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
iGATE
July 2017
Price: USD 1,250.00
Biobanking: Developing Smart, Sustainable and Ethically Compliant Biorepositories for the Future Summary GBI Research’s latest report, "...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
CBR Pharma Insights
December 2015
Price: USD 2,995.00
Innovation Tracking Factbook 2018: An Assessment of the Pharmaceutical Pipeline Summary GBI Research’s latest report “Innovation Tracking Factbook...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
CBR Pharma Insights
December 2018
Price: USD 2,995.00
Global Clinical Trials - Current Trends and Recent Advancement Summary GBI Research’s latest report, Global Clinical Trials - Current Trends and...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
CBR Pharma Insights
January 2019
Price: USD 2,995.00
PI3K Signaling Pathway Analysis: A Shifting Â鶹Դ´ed and Pipeline Product Landscape, as Blockbusters Expire and Development Moves Towards Downstream...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
CBR Pharma Insights
July 2018
Price: USD 2,995.00
Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Â鶹Դ´ and Increasing Usage of Complex Biologics during the...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
CBR Pharma Insights
November 2016
Price: USD 2,995.00
Ìý
